Published in Best Pract Res Clin Gastroenterol on February 01, 2003
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease | NCT00114465
On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig Dis Sci (2007) 1.04
The Role of Antibiotics in Inflammatory Bowel Disease. Curr Treat Options Gastroenterol (2005) 0.92
The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch (2014) 0.86
Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. Surg Today (2009) 0.80
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology (2003) 4.40
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol (2005) 2.90
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol (2003) 1.51
Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer (2002) 1.22
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells. J Pathol (2012) 1.22
Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis (2002) 1.15
High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum (2007) 1.12
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials. Am J Gastroenterol (2005) 1.10
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis (2005) 1.06
Attachment and quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis (2014) 1.04
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis (2005) 1.03
Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol (2006) 1.02
Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol (2006) 0.98
Adalimumab in active ulcerative colitis: a "real-life" observational study. Dig Liver Dis (2013) 0.98
An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum (2007) 0.95
Parental bonding and inflammatory bowel disease. Psychosomatics (2010) 0.93
Adult attachment and early parental experiences in patients with Crohn's disease. Psychosomatics (2010) 0.93
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue. World J Gastroenterol (2006) 0.93
Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum (2005) 0.90
Antimicrobials in the management of inflammatory bowel disease. Digestion (2006) 0.89
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study. Inflamm Bowel Dis (2011) 0.89
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. J Clin Gastroenterol (2005) 0.88
Short-term outcomes of laparoscopy combined with enhanced recovery pathway after ileocecal resection for Crohn's disease: a case-matched analysis. J Gastrointest Surg (2012) 0.84
Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease. J Clin Microbiol (2009) 0.83
Extramedullary spinal neurosarcoidosis: report of two cases. Eur Neurol (2006) 0.83
Probiotics for the treatment of postoperative complications following intestinal surgery. Best Pract Res Clin Gastroenterol (2003) 0.83
Barrier effect of Esoxx(®) on esophageal mucosal damage: experimental study on ex-vivo swine model. Clin Exp Gastroenterol (2012) 0.83
Obturator mononeuropathy caused by lipomatosis of the nerve: a case report. Muscle Nerve (2008) 0.83
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. Intern Emerg Med (2011) 0.82
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls. J Behav Med (2012) 0.81
Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy. Dermatology (2007) 0.81
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis. World J Gastroenterol (2013) 0.81
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing. Inflamm Bowel Dis (2010) 0.81
VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics. Gastroenterol Clin North Am (2005) 0.81
Standard treatment of ulcerative colitis. Dig Dis (2003) 0.80
Sympathetic hyperactivity in patients with ulcerative colitis. Clin Auton Res (2007) 0.80
Management of pouch dysfunction or pouchitis with an ileoanal pouch. Best Pract Res Clin Gastroenterol (2004) 0.80
Probiotics in gastroenterology. Curr Opin Gastroenterol (2002) 0.80
Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis (2011) 0.80
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. World J Gastroenterol (2010) 0.79
Role of conventional therapies in the era of biological treatment in Crohn's disease. World J Gastroenterol (2011) 0.78
Motor cortex excitability changes following a lesion in the posterior columns of the cervical spinal cord. Neurosci Lett (2008) 0.78
Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center. Eur J Gastroenterol Hepatol (2014) 0.78
The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis. Expert Rev Gastroenterol Hepatol (2015) 0.78
Infliximab in the treatment of Crohn's disease. Ther Clin Risk Manag (2007) 0.78
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? Int J Colorectal Dis (2013) 0.77
CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Int J Colorectal Dis (2003) 0.77
Management of inflammatory bowel disease: does rifaximin offer any promise? Chemotherapy (2005) 0.77
MR atypical Wernicke encephalopathy showing extensive brain stem and diencephalic involvement. J Neuroimaging (2010) 0.76
The role of Budesonide-MMX in active ulcerative colitis. Expert Rev Gastroenterol Hepatol (2014) 0.76
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease. World J Gastroenterol (2011) 0.75
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. Pathology (2014) 0.75